1998
DOI: 10.1016/s0041-0101(98)00156-1
|View full text |Cite
|
Sign up to set email alerts
|

What can toxins tell us for drug discovery?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
38
0
5

Year Published

2001
2001
2012
2012

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(43 citation statements)
references
References 9 publications
0
38
0
5
Order By: Relevance
“…Thus, the isolation and functional characterization of venom components provides a basis for understanding the mechanisms and/or future molecular models of venom action (21,22).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the isolation and functional characterization of venom components provides a basis for understanding the mechanisms and/or future molecular models of venom action (21,22).…”
Section: Discussionmentioning
confidence: 99%
“…Subtle functional differences in some venoms components, which may confer distinct pharmacological activities to proteins from the same family but distinctly expressed in L. muta and L. stenophrys, may be responsible for speciesspecific effects. Our proteomic analysis may serve as a starting point for studying structure-function correlations of individual toxins aiming at the development of new research tools and drugs of potential clinical use [61][62][63]. It is also worth to notice that though intraspecific variation in venom toxins may inform us about evolutionary processes acting at the species or population level, it represents also a source of Numbers refer to the reverse-phase HPLC separation shown in Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Other mutations can include the selective expression of a particular domain, such as the expression of the disintegrin domain from snake venom metalloprotease, ADAM-type (SVMP/ADAM) toxins in viperid venoms (21). These toxins have an unusual combination of precise specificity and extreme potency, characteristics that make them particularly amenable for use as investigational ligands or as leads for drug design and development (22)(23)(24).…”
Section: Molecular and Cellular Proteomics 7:215-246 2008mentioning
confidence: 99%